LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 45.61 | 770.25 | 1655 | 5813 | 0.2847 | 0.2999 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.83 | 770.25 | 1517 | 6223 | 0.2438 | 0.2521 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.83 | 770.25 | 1734 | 6223 | 0.2786 | 0.3089 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.05 | 770.25 | 1536 | 6629 | 0.2317 | 0.2489 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 50.05 | 770.25 | 1760 | 6629 | 0.2655 | 0.3049 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.27 | 770.25 | 1532 | 7058 | 0.2170 | 0.2400 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 52.27 | 770.25 | 1764 | 7058 | 0.2499 | 0.2960 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.49 | 770.25 | 1542 | 7555 | 0.2041 | 0.2346 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 54.49 | 770.25 | 1662 | 7555 | 0.2200 | 0.2630 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.71 | 770.25 | 1552 | 8001 | 0.1940 | 0.2306 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 56.71 | 770.25 | 1725 | 8001 | 0.2156 | 0.2697 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.94 | 770.25 | 1544 | 8444 | 0.1828 | 0.2230 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 58.94 | 770.25 | 1687 | 8444 | 0.1998 | 0.2548 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 61.16 | 770.25 | 1536 | 8892 | 0.1727 | 0.2160 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 61.16 | 770.25 | 1764 | 8892 | 0.1984 | 0.2647 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.39 | 770.25 | 1553 | 9326 | 0.1665 | 0.2152 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 63.39 | 770.25 | 1808 | 9326 | 0.1939 | 0.2676 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.61 | 770.25 | 1560 | 9736 | 0.1602 | 0.2127 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 65.61 | 770.25 | 1799 | 9736 | 0.1848 | 0.2608 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.83 | 770.25 | 1568 | 10078 | 0.1556 | 0.2112 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.83 | 770.25 | 1847 | 10078 | 0.1833 | 0.2659 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.05 | 770.25 | 1571 | 10413 | 0.1509 | 0.2089 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.05 | 770.25 | 1786 | 10413 | 0.1715 | 0.2509 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.27 | 770.25 | 1559 | 10730 | 0.1453 | 0.2039 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.27 | 770.25 | 1738 | 10730 | 0.1620 | 0.2388 | MN20160304_L02 | M17 |